CAS 54631-24-2

DL-threo-Ritalinic Acid

Kontrolliertes Produkt

CAS: 54631-24-2

Formel: C₁₃H₁₇NO₂

Farbe und Form: Neat

Molekulargewicht: 219.28

Ref: TR-R533120

DL-threo-Ritalinic Acid Hydrochloride

Kontrolliertes Produkt

CAS: 54631-24-2

Formel: C₁₃H₁₈ClNO₂

Farbe und Form: Neat

Molekulargewicht: 255.74

Ref: TR-R533110

DL-threo-Ritalinic Acid (1 mg/ml in Acetonitrile)

Kontrolliertes Produkt

CAS: 54631-24-2

Formel: C₁₃H₁₇NO₂

Farbe und Form: Single Solution

Molekulargewicht: 219.28

Ref: TR-KIT7160

DL-threo-Ritalinic Acid Hydrochloride (1mg/ml in Acetonitrile)

Kontrolliertes Produkt

CAS: 54631-24-2

Formel: C₁₃H₁₈ClNO₂

Farbe und Form: Single Solution

Molekulargewicht: 255.74

Ref: TR-KIT7155

DL-threo-Ritalinic acid

Kontrolliertes Produkt

CAS: 54631-24-2

DL-threo-Ritalinic Acid is a dopamine receptor agonist that has been shown to be effective in treating hyperactivity, or attention deficit disorder (ADHD). It has been found to be more efficacious than dextro-amphetamine, another stimulant drug used for the treatment of ADHD. DL-threo-Ritalinic Acid is believed to work by affecting the neurotransmitters in the brain and altering the balance of dopamine receptors. In a two-way crossover study, preschool children were given either 0.5mg/kg of DL-threo-Ritalinic Acid or placebo for three days. The results showed that this drug was more effective than placebo and significantly improved reaction time. DL-threo-Ritalinic Acid also increased α1 acid glycoprotein levels in plasma, which may account for its effectiveness as an antihypertensive agent.

Formel: C₁₃H₁₇NO₂

Reinheit: Min. 95%

Molekulargewicht: 219.28 g/mol

Ref: 3D-IR180350

DL-threo-Ritalinic acid

CAS: 54631-24-2

Formel: C₁₃H₁₇NO₂

Farbe und Form: Solid

Molekulargewicht: 219.2796

Ref: IN-DA003AJP